Additionally, a transcriptome analysis involved in mouse models of NAFLD and liver tissues from patients had reported the expression of SOX9 and SMPD3 (Teufel et al., 2016). Here, SOX9 is linked to metabolic dysfunction-associated steatotic liver disease.